v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A1 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series S-1 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series I Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series M Preferred Stock [Member]
Preferred Stock [Member]
Series Q Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series V Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 28, 2024 $ 8,552 $ 1,321 $ 9 $ 62,207 $ (56,879) $ (2,317) $ 3,925 $ 24,811
Balance, shares at Dec. 28, 2024 23,480 100,000 34,207 17,000 3,200 925,212 5,000 15,417,693          
Common stock issued for consulting agreement 94 94
Common stock issued for consulting agreement, shares               15,499          
Foreign currency adjustment 3,633 3,633
Net loss (2,392) (425) (2,817)
Common stock issued for warrants exercised 78 78
Common stock issued for warrants exercised, shares               45,455          
Common stock issued for Series V Preferred converted
Common stock issued for Series V Preferred converted, shares             (5,000) 600,000          
Balance at Mar. 29, 2025 $ 8,552 $ 1,321 $ 9 62,379 (59,271) 1,316 3,500 25,799
Balance, shares at Mar. 29, 2025 23,480 100,000 34,207 17,000 3,200 925,212 16,078,647          
Balance at Dec. 27, 2025 $ 7,993 $ 717 $ 725 $ 126 1,551,301 (402,710) (6,306) 3,500 1,155,346
Balance, shares at Dec. 27, 2025 100,000 34,207 17,000 925,212 126,474,169          
Common stock issued for consulting agreement 12 12
Common stock issued for consulting agreement, shares               6,000          
Common stock issued for Series Q convertible stock converted
Common stock issued for Series Q convertible stock converted, shares           (57,825)   57,825          
Common stock issued for Series I convertible stock converted
Common stock issued for Series I convertible stock converted, shares       (4,500)       450,000          
Common stock issued for Debenture converted 1,186 1,186
Common stock issued for Debenture converted, shares               160,562          
Common stock issued in lieu of notes payable obligation 26 26
Common stock issued in lieu of notes payable obligation, shares               17,698          
Foreign currency adjustment     8,077 8,077
Prio period adjustment 88 88
Net loss (271,493) (271,493)
Balance at Mar. 28, 2026 $ 7,993 $ 717 $ 725 $ 126 $ 1,552,525 $ (674,115) $ 1,771 $ 3,500 $ 893,242
Balance, shares at Mar. 28, 2026 100,000 34,207 12,500 867,387 127,166,254